JPMorgan cuts DraftKings stock rating on profitability concerns

JPMorgan downgraded DraftKings to Neutral from Overweight and cut its price target to $21 from $30 after the shares fell 21% Friday; the stock was cited at $18.51, down 46% year-to-date. The firm flagged negative trailing-12-month EBITDA of $87 million, uncertainty around fiscal 2027–28 projections, promotional competition and execution risks tied to the Predictions platform. DraftKings’ Q3 2026 revenue rose 16% to $1.33 billion but missed forecasts, while adjusted loss per share of $0.53 was wider than the expected $0.36; several other analysts also cut targets or ratings.

Analysis

The core issue is not whether DraftKings can grow revenue; it is whether incremental revenue can translate into durable EBITDA while customer acquisition remains promotional. The implied 2027 flow-through cited by JPMorgan is a demanding execution hurdle, so another guidance reset could hurt both earnings estimates and the multiple investors assign to them. Treat the Predictions opportunity as optionality, not as a dependable base-case earnings contributor: regulatory limits would impair the investment thesis, while continued spend could dilute near-term profitability even if the market expands.

The downgrade cluster raises the risk of near-term estimate cuts, but analyst targets are not a valuation floor. Conversely, after a sharp repricing, a short initiated indiscriminately risks a squeeze if promotional intensity eases or management demonstrates operating leverage. Over 1–3 months, monitor guidance, customer-acquisition spend, and actual EBITDA conversion; over 6–18 months, the key swing factor is whether the sector’s promotional arms race moderates and whether prediction-market access survives regulatory scrutiny. A contrarian upside case exists if competitors pull back promotions, but the article provides no evidence that this is occurring. No clear trade in JPM or UBS follows from their research actions.

Key Decisions for Investors

• Keep DKNG underweight rather than treating the lower share price or analyst targets as a buy signal. Reassess after the next results and guidance update, focusing on marketing/operating expense discipline and EBITDA conversion—not revenue growth alone.
• For a tactical bearish expression, consider a small, sector-hedged DKNG short only on a failed rebound or a further guidance/estimate cut. Cap risk: a sustained reduction in promotional intensity or clear improvement in EBITDA conversion would invalidate the thesis; avoid an unhedged short after the steep decline.
• Do not capitalize Predictions as core value until regulatory durability and unit economics are observable. Track relevant regulatory decisions and company disclosures on spend, customer acquisition, and contribution economics; the stated possibility of 2028 restrictions is a material downside catalyst, not a certainty.
• Before using options, compare implied volatility and skew with the event calendar; those inputs are absent here. If volatility is elevated, avoid paying outright put premium and consider defined-risk structures only when pricing and timing are verified.